Cullinan Therapeutics, Inc. - CGEM

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$1.311B

QoQ value delta ($000)

+$376M (+40.22%)

Implied price effect (QoQ)

+28.19%

Total shares

71,997,199

QoQ shares delta

+6,176,744 (+9.38%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 184 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
MPM BioImpact LLC	177,207	9,731,341	10.81%
Lynx1 Capital Management LP	163,225	8,963,500	18.86%
BVF INC/IL	104,719	5,750,683	2.68%
BlackRock, Inc.	95,288	5,232,766	0.0%
PRICE T ROWE ASSOCIATES INC /MD/	69,672	3,825,950	0.01%
STATE STREET CORP	66,805	3,668,627	0.0%
Kynam Capital Management, LP	56,708	3,114,132	3.13%
VANGUARD CAPITAL MANAGEMENT LLC	47,602	2,614,066	0.0%
RTW INVESTMENTS, LP	43,054	2,364,347	0.37%
Siren, L.L.C.	34,478	1,893,410	0.7%
GEODE CAPITAL MANAGEMENT, LLC	28,182	1,547,309	0.0%
Blue Owl Capital Holdings LP	28,039	1,539,764	4.22%
Venrock Adviser, LLC	25,129	1,379,965	0.76%
BOOTHBAY FUND MANAGEMENT, LLC	19,714	1,082,611	0.26%
DIMENSIONAL FUND ADVISORS LP	19,061	1,046,694	0.0%
GOLDMAN SACHS GROUP INC	18,239	1,001,598	0.0%
Affinity Asset Advisors, LLC	15,947	875,760	0.72%
VANGUARD PORTFOLIO MANAGEMENT LLC	13,452	738,741	0.0%
BOONE CAPITAL MANAGEMENT LLC	12,827	704,442	3.0%
Elmind Capital, LP	12,564	690,000	3.16%
MORGAN STANLEY	11,454	629,035	0.0%
TWIN FOCUS CAPITAL PARTNERS, LLC	10,843	595,489	1.1%
AQR CAPITAL MANAGEMENT LLC	10,586	581,338	0.0%
NORTHERN TRUST CORP	10,399	571,080	0.0%
CITADEL ADVISORS LLC	9,345	513,184	0.0%